AstraZeneca gets halfway invulnerability in ease EU antibody bargain Kumar Jeetendra | September 25, 2020 European authorities will pay claims over an agreed limit against AstraZeneca over side-effects from its potential COVID-19 vaccine, under different terms to a deal struck with Sanofi, an EU official told Reuters. The deals reflect different approaches by two of the world’s best drugmakers for protecting themselves as a debate rages about liabilities for vaccines …
New T-cell-based immunization procedure gives more extensive insurance against occasional flu Kumar Jeetendra | September 24, 2020 As Americans begin pulling their sleeves up for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternate vaccine approach that provides wider protection against seasonal flu. In a study published in Cell Reports Medicine today (Sept. 22), scientists describe a T-cell-based vaccine strategy that’s effective against multiple …
Molecular investigation of COVID-19’s subsequent wave shows freak infections connected to quick spread Kumar Jeetendra | September 24, 2020 Molecular analysis of COVID-19’s powerful second wave in Houston — from May 12 to July 7 — shows that a mutated virus strain linked to higher transmission and infection rates than the coronavirus strains that caused Houston’s first wave. Gene sequencing results from 5,085 COVID-positive patients analyzed at Houston Methodist since early March show a …
‘Quiet’ influx of neurological results might be on its way due to COVID-19 Kumar Jeetendra | September 23, 2020 Is the world ready a tide of neurological consequences which might be on its way as a result of COVID-19? A group of neuroscientists and clinicians are examining the potential link between COVID-19 and increased risk of Parkinson’s disease, and measures to get ahead of the curve. In a review paper published today, researchers put …
Mumbai’s KEM Hospital begins preliminaries of Covishield immunization Kumar Jeetendra | September 23, 2020 Bharat Biotech Place to Create intranasal COVID-19 vaccine: This is all you need to know Hyderabad-based Bharat Biotech announced on September 23 that it has collaborated with the Washington University School of Medicine to develop an intranasal COVID-19 vaccine. Here are seven things you need to know about the novel chimp-adenovirus vaccine candidate: Bharat Biotech …
Bharat Biotech set to create intranasal COVID-19 immunization: Here is everything you require to know Kumar Jeetendra | September 23, 2020 Bharat Biotech Place to Create intranasal COVID-19 vaccine: This is all you need to know Hyderabad-based Bharat Biotech announced on September 23 that it has collaborated with the Washington University School of Medicine to develop an intranasal COVID-19 vaccine. Here are seven things you need to know about the novel chimp-adenovirus vaccine candidate: Bharat Biotech …
Russia to enlist second COVID-19 antibody by October 15 Kumar Jeetendra | September 22, 2020 Russia expects to register a second possible vaccine against COVID-19 from October 15, the TASS news agency mentioned Russian consumer security watchdog Rospotrebnadzor as saying on Tuesday. The vaccine was developed by Siberia’s Vector Institute, which completed early-stage human trials of the vaccine last week. Russia registered its first vaccine candidate, developed by Moscow’s Gamaleya …
Flu antibody doesn’t expand COVID-19 danger: Study Kumar Jeetendra | September 22, 2020 Receiving the influenza vaccine does not increase a person’s risk for contracting COVID-19 or aggravate related conditions or mortality, according to a study. The study, published in the Journal of Clinical and Translational Science, shows the flu vaccine is the single most important intervention to help stay healthy. Seasonal flu activity is unpredictable, and healthy …
Oxford Covid-19 immunization: Serum Institute starts phase 3 of clinical preliminary Kumar Jeetendra | September 21, 2020 The phase-III or the last stage of clinical trial of the Covid-19 vaccine’Covishield’, being developed by Oxford University, also fabricated by the Serum Institute of India (SII), began today at the state-run Sassoon General Hospital in Pune, Maharashtra on Monday, a senior official said. “We have begun the phase-III trials of the vaccine candidate. We’ll …
Electronic Vaccine Intelligence Network to follow COVID-19 antibody Kumar Jeetendra | September 21, 2020 The Electronic Vaccine Intelligence Network (eVIN) system, which provides real-time information on vaccine stocks and storage temperatures across all cold chain points in the nation, has been enhanced to deal with the needs for distribution and tracking of COVID-19 vaccine, whenever it becomes available, the Rajya Sabha was informed on September 20. A national expert …
Chikungunya: The silent vector borne co-infection in Monsoon season Kumar Jeetendra | September 20, 2020 The prevalence of fever and joint pain is so common of symptoms that it overlaps with almost any prevalent disease in the tropics and hence for the better part of the virulent pathway of CHIK virus in the body, the patients remain asymptomatic to the detection of Chikungunya, thereby making it more life-threatening and requiring …
New polygenic danger score to help foresee the chances of medications causing liver harm Kumar Jeetendra | September 20, 2020 The ancient Romans studied the livers of sacrificial animals to read omens and create prophesies. Researchers at Tokyo Medical and Dental University (TMDU) and Takeda-CiRA program alongside a world-wide group of collaborators, have devised a polygenic risk score (PRS) based on liver genomics that can predict the probability of medications causing liver damage. Adding new …
